Please use this identifier to cite or link to this item:
Title: Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
Austin Authors: Villemagne, Victor L ;Pike, Kerryn E;Darby, David G;Maruff, Paul;Savage, Greg;Ng, S ;Ackermann, Uwe ;Cowie, T F;Currie, J;Chan, S G;Jones, G;Tochon-Danguy, Henri;O'Keefe, Graeme J;Masters, Colin L ;Rowe, Christopher C 
Affiliation: Department of Nuclear Medicine, Centre for PET, Austin Health, 145 Studley Road, Heidelberg, VIC 3084, Australia
Issue Date: 14-Feb-2008
Publication information: Neuropsychologia 2008; 46(6): 1688-97
Abstract: Approximately 30% of healthy persons aged over 75 years show Abeta deposition at autopsy. It is postulated that this represents preclinical Alzheimer's disease (AD). We evaluated the relationship between Abeta burden as assessed by PiB PET and cognitive decline in a well-characterized, non-demented, elderly cohort. PiB PET studies and cognitive tests were performed on 34 elderly participants (age 73+/-6) from the longitudinal Melbourne Healthy Aging Study (MHAS). Subjects were classified as being cognitively 'stable' or 'declining' by an independent behavioural neurologist based on clinical assessment and serial word-list recall scores from the preceding 6-10 years. Decline was calculated from the slope of the word-list recall scores. Abeta burden was quantified using Standardized Uptake Value normalized to cerebellar cortex. Ten subjects were clinically classified as declining. At the time of the PET scans, three of the declining subjects had mild cognitive impairment, one had AD, and six were declining but remained within the normal range for age on cognitive tests. Declining subjects were much more likely to show cortical PiB binding than stable subjects (70% vs. 17%, respectively). Neocortical Abeta burden correlated with word-list recall slopes (r=-0.78) and memory function (r=-0.85) in the declining group. No correlations were observed in the stable group. Abeta burden correlated with incident memory impairment and the rate of memory decline in the non-demented ageing population. These observations suggest that neither memory decline nor Abeta deposition are part of normal ageing and likely represent preclinical AD. Further longitudinal observations are required to confirm this hypothesis.
DOI: 10.1016/j.neuropsychologia.2008.02.008
Type: Journal Article
Subjects: Age Factors
Aged, 80 and over
Alzheimer Disease.complications.diagnosis
Amyloid beta-Peptides.metabolism
Brain.pathology.radionuclide imaging
Brain Mapping
Cognition Disorders.etiology.metabolism.radionuclide imaging
Image Processing, Computer-Assisted
Middle Aged
Neuropsychological Tests
Positron-Emission Tomography
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 29, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.